Concepedia

Philip Fernsten

PF

Statistics

Publications

15

Citations

1K

H-Index

14

Active since

1984

Affiliations

University of North Carolina at Chapel Hill(Current)

National Cancer Institute

Pfizer (United States)

National Institutes of Health

Charité - Universitätsmedizin Berlin

Philip Fernsten is an author at University of North Carolina at Chapel Hill specializing in immunology, antibody characterization, and monoclonal antibodies.

Publications per year

1984–2011

15

Publications

15

Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

A de Roux, Beate Schmöele-Thoma, George R. Siber et al. · Clinical Infectious Diseases · 2008 · 267 citations · Full text

, , +17

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A

David Cooper, Xinhong Yu, Mohinder Sidhu et al. · Vaccine · 2011 · 230 citations

, , +14

Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2.

Michael S. Lan, Olivera J. Finn, Philip Fernsten et al. · PubMed · 1985 · 113 citations

, , +17

Establishment of a New Human Pneumococcal Standard Reference Serum, 007sp

David Goldblatt, Brian D. Plikaytis, Mustafa Akkoyunlu et al. · Clinical and Vaccine Immunology · 2011 · 108 citations · Full text

, , +17

Monoclonal Antibodies Against Human Pancreatic Adenocarcinoma: Distribution of DU-PAN-2 Antigen on Glandular Epithelia and Adenocarcinomas<xref ref-type="fn" rid="FN2">2</xref>

Michael J. Borowitz, Francis L. Tuck, William F. Sindelar et al. · JNCI Journal of the National Cancer Institute · 1984 · 69 citations

, , +16

1–5 of 15